MATTHEW RICHARDSON: Open Payments
NPI 1649459900 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 31 payments from 8 companies in 2025. Trend: 2023 $784 · 2024 $372 · 2025 $702
Food & beverage: $590Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $204 |
| Lundbeck LLC | 9 | $171 |
| ABBVIE INC. | 5 | $132 |
| Janssen Pharmaceuticals, Inc | 5 | $85 |
| Averitas Pharma Inc. | 1 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, UZEDY, ABILIFY ASIMTUFII, REXULTI, INVEGA SUSTENNA, QUTENZA, SPRAVATO, INGREZZA.
Industry payments across TX — which companies pay providers there.
